Join the Migraine group to help and get support from people like you.
Migraine News (Page 2)
Related terms: Migraine Headache, Hemiplegic Migraine, Complicated Migraine, Basilar-Type Migraine, Basilar Artery Migraine
Older Adults With Migraine Experienced Higher Depression Risk During Pandemic
TUESDAY, Nov. 26, 2024 – During the pandemic, older adults with migraine experienced a substantial increase in the risk for depression, regardless of previous history, than before the pandemic and...
FDA Approves Nerivio for Migraine Treatment in Children Aged 8 Years and Older
FRIDAY, Nov. 22, 2024 – The U.S. Food and Drug Administration has expanded the age indication for Nerivio, making it the first and only remote electrical neuromodulation (REN) wearable for migraine...
Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
TUESDAY, Oct. 29, 2024 – In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Annals of...
Study Addresses Differentiating Meniere Disease, Vestibular Migraine
THURSDAY, Oct. 3, 2024 – The dissociation between pathological caloric testing and a normal video head impulse test can differentiate between Meniere disease (MD) and vestibular migraine (VM),...
Review Compares Drug Interventions for Acute Migraine Treatment
MONDAY, Sept. 23, 2024 – All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom, for the acute treatment of migraine among adults,...
Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine
WEDNESDAY, Sept. 18, 2024 – Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine...
Monoclonal Antibody Tops Placebo for Reducing Migraine Frequency
WEDNESDAY, Sept. 4, 2024 – The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing...
Migraine Drug Ubrelvy May Stop Headaches Before They Start
THURSDAY, Aug. 29, 2024 – A migraine drug can help stop the devastating headaches in their tracks, allowing sufferers to go about their daily lives with little to no symptoms, a new clinical trial...
Ubrogepant Administered During Prodrome Beneficial for Migraine
WEDNESDAY, Aug. 28, 2024 – For adults experiencing migraine attacks with moderate-to-severe headache pain, ubrogepant administered during prodrome is beneficial for patient-reported outcomes,...
No Link Found Between Migraines, Parkinson's Disease
FRIDAY, Aug. 23, 2024 – Women who suffer frequent migraines don’t have any increased risk of developing Parkinson’s disease, finds a new study that refutes earlier research. “These results are reass...
Migraine in Women Not Linked to Risk for Parkinson Disease
THURSDAY, Aug. 22, 2024 – Migraine is not associated with an increased risk for developing Parkinson disease (PD) among women, according to a study published online Aug. 21 in Neurology. Ricarda S....
Most Traditional Cardiovascular Risk Factors Not Linked to Migraine
WEDNESDAY, July 31, 2024 – For women, many traditional cardiovascular risk factors (CVRFs) are inversely associated with migraine risk, according to a study published online July 31 in Neurology....
High Blood Pressure Might Help Spur Migraines
THURSDAY, Aug. 1, 2024 – High blood pressure might increase a woman’s odds of suffering migraines, a new study finds. Specifically, high diastolic blood pressure is linked to a slightly higher risk o...
FDA Medwatch Alert: Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Issues Recall of One Lot of Healthy Living Over the Counter (OTC) Migraine Relief
July 18, 2024 – East Windsor, New Jersey. Aurobindo Pharma USA, Inc., on behalf of AuroHealth, is voluntarily recalling one lot (refer table below) of Healthy Living Migraine Relief, Acetaminophen 2...
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With Migraine
TUESDAY, July 16, 2024 – For patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and...
Further information
Related condition support groups
Migraine Prevention, Migraine Prophylaxis, Chronic Migraine, Headache
Related drug support groups
gabapentin, ibuprofen, amitriptyline, venlafaxine, propranolol, diclofenac, cyclobenzaprine, topiramate, Botox, view more... sumatriptan, Excedrin, Imitrex, erenumab, Excedrin Migraine, Ubrelvy, verapamil, cyproheptadine, Reglan, Migraine Relief, Nurtec ODT